What principles should govern the use of managed entry agreements?

TitleWhat principles should govern the use of managed entry agreements?
Publication TypeJournal Article
Year of Publication2011
AuthorsKlemp M, Frønsdal KB, Facey K
Corporate AuthorsHTAi Policy Forum
JournalInternational journal of technology assessment in health care
Volume27
Issue1
Pagination77-83
Date Published2011 Jan
ISSN1471-6348
KeywordsBiomedical Technology; Education; Health Services Accessibility; Humans; Insurance, Health, Reimbursement; Time Factors
AbstractBACKGROUND: To ensure rapid access to new potentially beneficial health technologies, obtain best value for money, and ensure affordability, healthcare payers are adopting a range of innovative reimbursement approaches that may be called Managed Entry Agreements (MEAs). METHODS: The Health Technology Assessment International (HTAi) Policy Forum sought to identify why MEAs might be used, issues associated with implementation and develop principles for their use. A 2-day deliberative workshop discussed key papers, members' experiences, and collectively addressed four policy questions that resulted in this study. RESULTS: MEAs are used to give access to new technologies where traditional reimbursement is deemed inappropriate. Three different forms of MEAs have been identified: management of budget impact, management of uncertainty relating to clinical and/or cost-effectiveness, and management of utilization to optimize performance. The rationale for using these approaches and their advantages and disadvantages differ. However, all forms of MEA should take the form of a formal written agreement among stakeholders, clearly identifying the rationale for the agreement, aspects to be assessed, methods of data collection and review, and the criteria for ending the agreement. CONCLUSIONS: MEAs should only be used when HTA identifies issues or concerns about key outcomes and/or costs and/or organizational/budget impacts that are material to a reimbursement decision. They provide patient access and can be useful to manage technology diffusion and optimize use. However, they are administratively complex and may be difficult to negotiate and their effectiveness has yet to be evaluated.
URLhttp://journals.cambridge.org/HTAPolicyForum2
DOI10.1017/S0266462310001297
Alternate JournalInt J Technol Assess Health Care